NO960724D0 - Middel for transdermal applisering inneholdende gestodenestere - Google Patents

Middel for transdermal applisering inneholdende gestodenestere

Info

Publication number
NO960724D0
NO960724D0 NO960724A NO960724A NO960724D0 NO 960724 D0 NO960724 D0 NO 960724D0 NO 960724 A NO960724 A NO 960724A NO 960724 A NO960724 A NO 960724A NO 960724 D0 NO960724 D0 NO 960724D0
Authority
NO
Norway
Prior art keywords
gestoden
esters
transdermal application
application containing
transdermal
Prior art date
Application number
NO960724A
Other languages
English (en)
Norwegian (no)
Other versions
NO960724L (no
Inventor
Ralph Lipp
Henry Laurent
Clemens Gunther
Jutta Riedl
Peter Esperling
Ulrich Tauber
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO960724L publication Critical patent/NO960724L/no
Publication of NO960724D0 publication Critical patent/NO960724D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO960724A 1993-08-26 1996-02-23 Middel for transdermal applisering inneholdende gestodenestere NO960724D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4329242A DE4329242A1 (de) 1993-08-26 1993-08-26 Mittel zur transdermalen Applikation enthaltend Gestodenester
PCT/EP1994/002496 WO1995005827A1 (fr) 1993-08-26 1994-07-29 Agent contenant des esters de gestodene pour application transdermique

Publications (2)

Publication Number Publication Date
NO960724L NO960724L (no) 1996-02-23
NO960724D0 true NO960724D0 (no) 1996-02-23

Family

ID=6496410

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960724A NO960724D0 (no) 1993-08-26 1996-02-23 Middel for transdermal applisering inneholdende gestodenestere

Country Status (10)

Country Link
US (1) US5858394A (fr)
EP (1) EP0715518A1 (fr)
JP (1) JPH09504783A (fr)
AU (1) AU693802B2 (fr)
CA (1) CA2170371A1 (fr)
DE (1) DE4329242A1 (fr)
FI (1) FI960800A (fr)
HU (1) HUT73236A (fr)
NO (1) NO960724D0 (fr)
WO (1) WO1995005827A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
US6540332B2 (en) * 1997-07-15 2003-04-01 Silverbrook Research Pty Ltd Motion transmitting structure for a nozzle arrangement of a printhead chip for an inkjet printhead
US6846496B1 (en) * 1999-10-15 2005-01-25 Orion Corporation Treatment of osteoporosis
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
DE10060852A1 (de) * 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
US7330822B1 (en) * 2001-05-29 2008-02-12 Oracle International Corporation Methods and systems for managing hierarchically organized and interdependent tasks and issues
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
US6652020B2 (en) * 2002-04-09 2003-11-25 Norco Industries, Inc. Reinforcing bracket for trailer-frame butt joints
RS50428B (sr) 2003-02-21 2009-12-31 Bayer Schering Pharma Aktiengesellschaft, Uv-stabilni transdermalni flasteri
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
EA011160B1 (ru) * 2003-12-12 2009-02-27 Шеринг Акциенгезельшафт Композиция для трансдермальной доставки гормонов без необходимости использования агентов, усиливающих проникновение, и ее применения
UA89766C2 (en) 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US7468470B2 (en) 2004-03-26 2008-12-23 Schering Ag Medicinal patch that leaves less adhesive residue when removed
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (fr) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Formulations d'hormones substitutives combinees naturelles et traitement hormonal substitutif
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546062A1 (de) * 1975-10-10 1977-04-21 Schering Ag Delta hoch 15 -steroide
US4081537A (en) * 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
EP0370220B1 (fr) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Composition de Gestoden à application transdermique
PT99338A (pt) * 1990-10-29 1992-10-30 Alza Corp Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica
JPH0650974A (ja) * 1992-07-29 1994-02-25 Nec Corp 免疫センサシステムおよびこれを用いた免疫測定方法

Also Published As

Publication number Publication date
FI960800A0 (fi) 1996-02-22
JPH09504783A (ja) 1997-05-13
US5858394A (en) 1999-01-12
NO960724L (no) 1996-02-23
CA2170371A1 (fr) 1995-03-02
DE4329242A1 (de) 1995-03-02
AU693802B2 (en) 1998-07-09
HU9503654D0 (en) 1996-02-28
WO1995005827A1 (fr) 1995-03-02
HUT73236A (en) 1996-07-29
FI960800A (fi) 1996-02-22
EP0715518A1 (fr) 1996-06-12
AU7533694A (en) 1995-03-21

Similar Documents

Publication Publication Date Title
NO960724D0 (no) Middel for transdermal applisering inneholdende gestodenestere
DE69431209D1 (de) Transdermale prostaglandin-zusammensetzung
DK0685105T3 (da) Holder til CD
FI931736A0 (fi) Biodegraderbart tgf-b-leveranssystem foer benregeneration
FI960165A0 (fi) Säädetty apoptoosi
DE69426402D1 (de) Photothermographische Materialien
DE69411222D1 (de) Schmalbundiges Mach-Zehnder Filter
BR9403908A (pt) Dispositivo de apoio
BR9403900A (pt) Dispositivo de apoio
DE69301600D1 (de) Photothermographische Materialien
DE69427178T2 (de) Modulatoren
NO932040D0 (no) Varslingsanordning for taksluk
DK76393D0 (da) Underlagsmateriale
DK0697850T3 (da) Klæbemiddel til tandproteser
DK33093A (da) Holder til diske
KR950001439U (ko) 전주 지지대
FI96140C (fi) Nopea hiilidioksidiherkkä mikroelektrodi
KR950002733U (ko) 분리형 신발끈 지지구
ITVE930007A0 (it) Allestimento per esposizione
BR7302061U (pt) Suporte de penachos
SE9300970D0 (sv) Braensleinmatare foer fastbraenslepannor
LT2338B (lt) 5-arginilaminonaftalin-1-sulfoamidu dihidrochloridai kaip pusiauproduktai 5-arginilaminonaftalin-1-sulfamidu gavimui
BR9301986A (pt) Suporte
BR7300553U (pt) Suporte
SE9302521D0 (sv) Foerfarande vid flerstegsblekning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application